These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19864591)
21. IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation. Lusty E; Poznanski SM; Kwofie K; Mandur TS; Lee DA; Richards CD; Ashkar AA Mol Immunol; 2017 Aug; 88():138-147. PubMed ID: 28644973 [TBL] [Abstract][Full Text] [Related]
22. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989 [TBL] [Abstract][Full Text] [Related]
23. Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response. Nomura A; Takada H; Jin CH; Tanaka T; Ohga S; Hara T Exp Hematol; 2001 Oct; 29(10):1169-76. PubMed ID: 11602318 [TBL] [Abstract][Full Text] [Related]
27. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Lauwerys BR; Renauld JC; Houssiau FA Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269 [TBL] [Abstract][Full Text] [Related]
28. Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages. Endsley JJ; Endsley MA; Estes DM J Leukoc Biol; 2006 Jan; 79(1):71-9. PubMed ID: 16275895 [TBL] [Abstract][Full Text] [Related]
29. IL-22: An Underestimated Player in Natural Resistance to Tuberculosis? Ronacher K; Sinha R; Cestari M Front Immunol; 2018; 9():2209. PubMed ID: 30319650 [TBL] [Abstract][Full Text] [Related]
30. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Tripp CS; Wolf SF; Unanue ER Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3725-9. PubMed ID: 8097322 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-26 activates macrophages and facilitates killing of Mycobacterium tuberculosis. Hawerkamp HC; van Geelen L; Korte J; Di Domizio J; Swidergall M; Momin AA; Guzmán-Vega FJ; Arold ST; Ernst J; Gilliet M; Kalscheuer R; Homey B; Meller S Sci Rep; 2020 Oct; 10(1):17178. PubMed ID: 33057074 [TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. Goodier MR; Londei M J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046 [TBL] [Abstract][Full Text] [Related]
33. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells. Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284 [TBL] [Abstract][Full Text] [Related]
35. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. Robinson CM; Nau GJ J Infect Dis; 2008 Aug; 198(3):359-66. PubMed ID: 18557702 [TBL] [Abstract][Full Text] [Related]
37. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation. Schierloh P; Alemán M; Yokobori N; Alves L; Roldán N; Abbate E; del C Sasiain M; de la Barrera S Immunology; 2005 Dec; 116(4):541-52. PubMed ID: 16313368 [TBL] [Abstract][Full Text] [Related]
38. A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy. Becker-Hapak MK; Shrestha N; McClain E; Dee MJ; Chaturvedi P; Leclerc GM; Marsala LI; Foster M; Schappe T; Tran J; Desai S; Neal CC; Pence P; Wong P; Wagner JA; Russler-Germain DA; Zhu X; Spanoudis CM; Gallo VL; Echeverri CA; Ramirez LL; You L; Egan JO; Rhode PR; Jiao JA; Muniz GJ; Jeng EK; Prendes CA; Sullivan RP; Berrien-Elliott MM; Wong HC; Fehniger TA Cancer Immunol Res; 2021 Sep; 9(9):1071-1087. PubMed ID: 34244297 [TBL] [Abstract][Full Text] [Related]